• Something wrong with this record ?

Synthetic mRNA is a more reliable tool for the delivery of DNA-targeting proteins into the cell nucleus than fusion with a protein transduction domain

I. Leontovyc, D. Habart, S. Loukotova, L. Kosinova, J. Kriz, F. Saudek, T. Koblas,

. 2017 ; 12 (8) : e0182497. [pub] 20170814

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18016430

Cell reprogramming requires efficient delivery of reprogramming transcription factors into the cell nucleus. Here, we compared the robustness and workload of two protein delivery methods that avoid the risk of genomic integration. The first method is based on fusion of the protein of interest to a protein transduction domain (PTD) for delivery across the membranes of target cells. The second method relies on de novo synthesis of the protein of interest inside the target cells utilizing synthetic mRNA (syn-mRNA) as a template. We established a Cre/lox reporter system in three different cell types derived from human (PANC-1, HEK293) and rat (BRIN-BD11) tissues and used Cre recombinase to model a protein of interest. The system allowed constitutive expression of red fluorescence protein (RFP), while green fluorescence protein (GFP) was expressed only after the genomic action of Cre recombinase. The efficiency of protein delivery into cell nuclei was quantified as the frequency of GFP+ cells in the total cell number. The PTD method showed good efficiency only in BRIN-BD11 cells (68%), whereas it failed in PANC-1 and HEK293 cells. By contrast, the syn-mRNA method was highly effective in all three cell types (29-71%). We conclude that using synthetic mRNA is a more robust and less labor-intensive approach than using the PTD-fusion alternative.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016430
003      
CZ-PrNML
005      
20200603140400.0
007      
ta
008      
180515s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0182497 $2 doi
035    __
$a (PubMed)28806415
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Leontovyc, Ivan $u Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
245    10
$a Synthetic mRNA is a more reliable tool for the delivery of DNA-targeting proteins into the cell nucleus than fusion with a protein transduction domain / $c I. Leontovyc, D. Habart, S. Loukotova, L. Kosinova, J. Kriz, F. Saudek, T. Koblas,
520    9_
$a Cell reprogramming requires efficient delivery of reprogramming transcription factors into the cell nucleus. Here, we compared the robustness and workload of two protein delivery methods that avoid the risk of genomic integration. The first method is based on fusion of the protein of interest to a protein transduction domain (PTD) for delivery across the membranes of target cells. The second method relies on de novo synthesis of the protein of interest inside the target cells utilizing synthetic mRNA (syn-mRNA) as a template. We established a Cre/lox reporter system in three different cell types derived from human (PANC-1, HEK293) and rat (BRIN-BD11) tissues and used Cre recombinase to model a protein of interest. The system allowed constitutive expression of red fluorescence protein (RFP), while green fluorescence protein (GFP) was expressed only after the genomic action of Cre recombinase. The efficiency of protein delivery into cell nuclei was quantified as the frequency of GFP+ cells in the total cell number. The PTD method showed good efficiency only in BRIN-BD11 cells (68%), whereas it failed in PANC-1 and HEK293 cells. By contrast, the syn-mRNA method was highly effective in all three cell types (29-71%). We conclude that using synthetic mRNA is a more robust and less labor-intensive approach than using the PTD-fusion alternative.
650    _2
$a zvířata $7 D000818
650    _2
$a buněčné jádro $x metabolismus $7 D002467
650    _2
$a buněčné klony $7 D002999
650    _2
$a DNA $x metabolismus $7 D004247
650    _2
$a průtoková cytometrie $7 D005434
650    12
$a technika přenosu genů $7 D018014
650    _2
$a genetické inženýrství $7 D005818
650    _2
$a zelené fluorescenční proteiny $x metabolismus $7 D049452
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a lidé $7 D006801
650    _2
$a integrasy $x metabolismus $7 D019426
650    _2
$a proteinové domény $7 D000072417
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a rekombinantní fúzní proteiny $x chemie $x metabolismus $7 D011993
650    _2
$a reprodukovatelnost výsledků $7 D015203
655    _2
$a časopisecké články $7 D016428
700    1_
$a Habart, David $u Department of Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Loukotová, Šárka $u Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0248561
700    1_
$a Kosinova, Lucie $u Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Kriz, Jan $u Department of Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Saudek, Frantisek $u Department of Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Koblas, Tomas $u Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 12, č. 8 (2017), s. e0182497
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28806415 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20200603140357 $b ABA008
999    __
$a ok $b bmc $g 1300054 $s 1013270
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 12 $c 8 $d e0182497 $e 20170814 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Archiving options